What is the best course of action for a patient with recurrent diarrhea that has been waxing and waning for 2 weeks after initial resolution?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Waxing and Waning Diarrhea After Initial Resolution

For a patient with diarrhea that resolved after 2 weeks but is now recurring in a waxing and waning pattern, you should conduct a clinical and laboratory reevaluation to exclude both persistent infectious causes and noninfectious conditions, particularly inflammatory bowel disease (IBD) and post-infectious irritable bowel syndrome (IBS), as symptoms lasting ≥14 days warrant consideration of these underlying etiologies. 1

Initial Assessment and Red Flags

Obtain a detailed history focusing on:

  • Stool characteristics: frequency, consistency (watery vs. bloody), nocturnal symptoms, and volume 1
  • Alarm features that mandate urgent evaluation: blood in stool, unintentional weight loss, fever, signs of dehydration (dizziness upon standing), or severe abdominal pain 1, 2
  • Travel history, dietary exposures (raw/undercooked meat, seafood, unpasteurized dairy), daycare attendance, sick contacts, and sexual practices 1
  • Medication review to identify potential diarrheogenic agents 1
  • Surgical history (particularly bowel resections that can cause bile acid diarrhea or bacterial overgrowth) 1
  • Systemic diseases: thyroid disorders, diabetes, or immunocompromising conditions 1

Physical examination should assess:

  • Hydration status and vital signs (orthostatic changes) 1
  • Abdominal examination for masses, tenderness, or distension 2

Diagnostic Workup

Since symptoms have persisted beyond 14 days with a waxing and waning pattern, testing is indicated: 1

First-line laboratory studies:

  • Stool studies: culture for bacterial pathogens (Salmonella, Shigella, Campylobacter, STEC), ova and parasites, Clostridioides difficile testing if risk factors present 1
  • Blood tests: complete blood count (to assess for anemia or leukocytosis), comprehensive metabolic panel (electrolytes, renal function), thyroid function tests, celiac serology (tissue transglutaminase IgA with total IgA) 1
  • Fecal calprotectin or lactoferrin if inflammatory bowel disease is suspected 1

The 2017 IDSA guidelines emphasize that noninfectious conditions, including IBD and post-infectious IBS, should be strongly considered as underlying etiologies in people with symptoms lasting ≥14 days with unidentified sources. 1 This is a critical distinction because the waxing and waning pattern after initial resolution suggests either persistent infection with intermittent shedding, post-infectious functional changes, or an underlying inflammatory condition that was unmasked by the initial infectious episode.

Management Strategy

Rehydration remains the cornerstone:

  • Reduced osmolarity oral rehydration solution (ORS) for mild to moderate dehydration 1
  • Intravenous fluids (lactated Ringer's or normal saline) only if severe dehydration, shock, altered mental status, or ORS failure 1

Dietary modifications:

  • Eliminate lactose-containing products (lactose intolerance can develop post-infectious diarrhea), alcohol, caffeine, and high-osmolar supplements 1, 3
  • Small frequent meals with easily digestible foods (bananas, rice, applesauce, toast, plain pasta) 1, 3
  • Maintain hydration with 8-10 glasses of clear liquids daily 3

Empiric antimicrobial therapy is NOT recommended for persistent watery diarrhea lasting ≥14 days without specific pathogen identification, as this duration makes acute bacterial infection less likely and risks selecting for resistant organisms. 1 The exception would be if stool studies identify a specific treatable pathogen.

Symptomatic management:

  • Loperamide may be considered in immunocompetent adults with watery (non-bloody) diarrhea without fever: initial dose 4 mg, then 2 mg after each unformed stool (maximum 16 mg/day) 1, 4
  • Avoid loperamide if there is any suspicion of inflammatory diarrhea, bloody stools, or fever, as this can precipitate toxic megacolon 1
  • Probiotics may reduce symptom severity and duration in immunocompetent patients 1

When to Escalate Care

Refer for gastroenterology evaluation if: 1, 2

  • Alarm features are present (blood in stool, weight loss, anemia, palpable abdominal mass)
  • Symptoms persist despite initial management and negative infectious workup
  • Quality of life is significantly impaired
  • Suspicion for IBD, celiac disease, or other chronic conditions requiring endoscopic evaluation

Consider endoscopy with biopsies if symptoms persist beyond 4 weeks with negative stool studies, as this can diagnose microscopic colitis, IBD, celiac disease, or other mucosal pathology. 1

Common Pitfalls to Avoid

  • Do not assume resolution means cure: The initial 2-week resolution followed by recurrence suggests either relapsing infection (parasites like Giardia or Cryptosporidium), post-infectious IBS, or unmasking of underlying IBD 1
  • Do not overlook bile acid diarrhea: If the patient has had prior ileal resection or cholecystectomy, empiric trial of bile acid sequestrants may be diagnostic and therapeutic 1
  • Do not continue empiric antibiotics without pathogen identification in persistent diarrhea, as this can worsen outcomes and promote resistance 1
  • Reassess fluid and electrolyte balance, nutritional status regularly in patients with persistent symptoms 1

The waxing and waning pattern after initial resolution is the key clinical clue that distinguishes this from simple acute infectious diarrhea and mandates a broader differential diagnosis including post-infectious functional disorders and chronic inflammatory conditions.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Diarrhea as a Clinical Challenge: General Practitioner Approach.

Digestive diseases (Basel, Switzerland), 2022

Guideline

Management of Levetiracetam-Induced Diarrhea

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.